Symptoms of Low Indole-3-Carbinol: Causes and Treatment
Deficiency
Symptoms & causes
Indole-3-carbinol (I3C) is a phytochemical from cruciferous vegetables, not an essential nutrient β no deficiency syndrome exists, but low cruciferous-vegetable intake has real implications for cancer-risk pathways and estrogen metabolism.
Indole-3-carbinol isn't a vitamin or mineral your body requires to function. It's a plant compound formed when you chew cruciferous vegetables like broccoli or kale. While there's no such thing as an I3C deficiency, the compound has been studied for its effects on estrogen metabolism and HPV-related conditions. The evidence is narrow and mostly preliminary, and supplements carry risks that food sources do not.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Who is most likely to run low
Some people are more prone to falling short than others β including many people on a weight-loss journey who are simply eating less.
- No clinical deficiency population exists. People with very low cruciferous intake lack the phytochemical's potential benefits.
- Those with hormone-sensitive conditions, recurrent respiratory papillomatosis, or concerns about estrogen metabolism may be specifically interested in I3C research.
How low levels are diagnosed
No blood test for I3C level. No deficiency marker exists.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Food sources: broccoli, Brussels sprouts, cabbage, cauliflower, kale, bok choy β highest I3C content when raw or lightly cooked; overcooking destroys glucosinolates. Supplements: sold as I3C (typically 200β400 mg/day) or as DIM (its downstream metabolite). The National Cancer Institute has studied I3C in cancer-prevention contexts, but it is not approved for any indication.
How to keep levels up
Not applicable β no deficiency to prevent. Eating cruciferous vegetables regularly is prudent for general health.
When to see a clinician
If considering I3C supplements for a hormone-sensitive condition or cancer risk reduction β discuss with an oncologist or endocrinologist rather than self-treating.
'Low Indole-3-Carbinol' β Why This Search Query Gets the Frame Wrong
If you're searching for symptoms of low indole-3-carbinol, you've likely encountered wellness sites that treat this plant compound like a vitamin deficiency waiting to happen. That framing is fundamentally incorrect.
Indole-3-carbinol (I3C) is not a nutrient your body makes or requires. It's a glucosinolate breakdown product that forms in your mouth the moment you bite into a Brussels sprout or chew a piece of raw broccoli. The plant stores glucobrassicin, an inactive precursor, and the physical act of chewing brings it into contact with an enzyme called myrosinase β that's when I3C is born. Without cruciferous vegetables on your fork, there's simply no I3C in your system.
This matters because the 'deficiency' framing implies your body has a baseline requirement that isn't being met. Essential nutrients like vitamin C or iron work that way β fall below a threshold and predictable symptoms appear. I3C doesn't operate on that model. It's a dietary phytochemical, one of thousands in plants, that may exert beneficial effects when consumed regularly but whose absence causes no specific disease state. The correct question isn't 'Do I have an I3C deficiency?' It's 'Am I eating enough cruciferous vegetables?'
Bottom line
The correct question is 'Am I eating enough cruciferous vegetables?' β not 'Do I have a deficiency of indole-3-carbinol?'
What I3C and DIM Actually Do: Estrogen Metabolism and Beyond
Once I3C forms in your mouth and reaches the stomach, it encounters gastric acid β and that's where the chemistry gets interesting. In the acidic environment of the stomach, I3C molecules condense into several compounds, the most notable being diindolylmethane, or DIM. This means that when you eat broccoli, you're effectively getting a precursor that your digestive system converts into DIM and other metabolites.
The primary biological story around I3C and DIM involves estrogen metabolism. Your body processes estrogen through several pathways in the liver, largely governed by CYP450 enzymes. One pathway, driven by CYP1A1, produces 2-hydroxyestrone (2-OHE1), a metabolite with relatively weak estrogenic activity. Another, driven by CYP1B1, produces 16Ξ±-hydroxyestrone (16Ξ±-OHE1), which binds more strongly to estrogen receptors and has been associated β in observational studies β with increased breast cancer risk. I3C and DIM appear to induce CYP1A1, shifting the balance toward 2-OHE1 production.
This mechanism is real and reproducible in laboratory studies. Cell culture and animal models show consistent shifts in estrogen metabolite ratios. But the leap from 'shifts a lab measurement' to 'prevents cancer in humans' is enormous, and that leap hasn't been made. The estrogen metabolism story is mechanistically plausible, but well-powered human trials confirming a cancer-prevention effect simply don't exist. The DIM page on our site covers that downstream metabolite in more detail; this page focuses on I3C as the food-derived precursor with its own distinct evidence base.
Bottom line
The estrogen-metabolism story is mechanistically plausible but not confirmed as a cancer-prevention tool in well-powered human trials; the DIM page covers the downstream metabolite β this page covers I3C as the food-derived precursor.
The Evidence From Human Trials: Cervical Dysplasia and Recurrent Respiratory Papillomatosis
If you dig into the human research on I3C, you won't find large cancer-prevention trials. What you will find are two narrow clinical contexts where I3C has been studied directly: cervical intraepithelial neoplasia (CIN) and recurrent respiratory papillomatosis (RRP). Both are HPV-driven conditions, and both have produced modest but intriguing signals.
The most cited trial comes from Bell and colleagues, published in Gynecologic Oncology in 2000. In a small placebo-controlled study of women with CIN 2/3, those taking 200 or 400 mg of I3C daily showed higher rates of lesion regression compared to placebo. The numbers were modest β this was not a cure β but they were statistically significant and have driven interest in I3C for HPV-related cervical changes ever since.
In recurrent respiratory papillomatosis, a rare condition where HPV causes wart-like growths in the airway, case series have reported reduced surgical frequency in patients taking I3C. These are small, uncontrolled observations, not randomized trials. They're promising enough that some laryngology centers discuss I3C as an adjunct, but not strong enough to change standard practice. The National Cancer Institute has funded research in both areas, and its PDQ summary on I3C remains the best single source for clinicians. The honest summary: I3C has its most credible human evidence in HPV-related conditions, not general cancer prevention. That's a nuance most consumer health sites gloss over entirely.
Bottom line
I3C has the most credible human evidence in HPV-related conditions, not general cancer prevention. This is a nuanced finding competitors don't convey accurately.
Safety Concerns: When I3C Supplements May Do Harm
Here's where the 'just take a supplement' instinct can lead people astray. I3C at food doses β the amount you get from a serving of broccoli β has no known safety issues. But supplement doses are a different animal entirely. A typical I3C capsule delivers 200 to 400 mg in a single bolus, which can be 20 to 50 times what you'd absorb from a meal of cruciferous vegetables. That concentrated dose changes the pharmacology.
Case reports have documented liver enzyme elevations in people taking I3C supplements. The mechanism isn't fully understood, but it's consistent enough that anyone using I3C should have liver function monitored. There are also theoretical concerns about thyroid function β high doses of glucosinolate derivatives can interfere with iodine uptake in animal models, though human data is sparse. More concretely, I3C is an inducer of CYP450 enzymes, particularly CYP1A1 and CYP1A2. That means it can accelerate the metabolism of drugs processed through those pathways, potentially reducing their effectiveness.
This interaction risk is especially relevant for hormone-modulating medications. Tamoxifen, oral contraceptives, and some chemotherapy agents are metabolized via CYP pathways that I3C can perturb. The NCI explicitly cautions against self-supplementation with I3C outside of clinical trials for this reason. If you're considering I3C for a hormone-sensitive condition or cancer risk reduction, this is a conversation for your oncologist or endocrinologist β not a decision to make in the supplement aisle.
Bottom line
I3C supplements carry meaningful interaction risk that food sources do not β the supplement dose can be 20 to 50 times what you get from a serving of broccoli, with different pharmacology.
Cruciferous Vegetables, GLP-1 Users, and Eating Less
If you're using a GLP-1 medication for weight management, cruciferous vegetables deserve a starring role on your plate β and not just because of I3C. These vegetables are uniquely suited to the reduced-intake eating pattern that GLP-1 drugs create.
Broccoli, cauliflower, kale, and Brussels sprouts deliver an exceptional nutrient package for very few calories. A cup of cooked broccoli has about 55 calories but provides fiber, folate, vitamin C, vitamin K, and those glucosinolates that give rise to I3C. The fiber is particularly valuable when your appetite is suppressed: it slows gastric emptying (complementing what GLP-1 already does), supports gut health, and helps you feel satisfied on smaller portions. The high water content and volume of cruciferous vegetables mean they fill your stomach without filling your calorie budget.
The practical challenge for GLP-1 users is that when you're not hungry, vegetables can be the first thing you skip. Protein and simple carbs often feel more appealing. But this is exactly when vegetable intake matters most β you're eating less overall, so every bite needs to count nutritionally. Lightly steaming broccoli or tossing shredded Brussels sprouts into a small portion of lean protein takes minimal effort and ensures you're getting the phytochemicals, fiber, and micronutrients that support long-term health. No supplement replicates this package. If you're managing weight with GLP-1 medication and want help structuring an eating plan that prioritizes nutrient density, a Curex clinician can help.
Bottom line
Cruciferous vegetables are the GLP-1 user's best friend β maximize them within a smaller eating pattern rather than replacing them with supplements.
What most pages leave out
Competitors writing about 'low I3C' typically invent deficiency symptoms like hormonal imbalance, fatigue, or cancer risk. The honest position is: no deficiency syndrome exists; the only human trial evidence is narrow (HPV-related conditions); supplement doses carry interaction risks that food amounts do not; and 'eat more broccoli' is better-supported advice than 'buy I3C capsules.'
We flag this so you can make an informed choice β not to scare you off.
βFrequently Asked Questions
There are no symptoms of low indole-3-carbinol because I3C is a phytochemical, not a nutrient your body requires. The relevant question is whether you're eating enough cruciferous vegetables β low intake may mean missing out on potential health benefits, but it doesn't cause a deficiency syndrome.
I3C modulates enzymes involved in estrogen metabolism, potentially shifting the balance toward less estrogenic metabolites. Human evidence for this effect is limited to narrow clinical contexts, primarily HPV-related conditions like cervical dysplasia and recurrent respiratory papillomatosis.
I3C converts to DIM in your stomach acid, so they're closely related. DIM is the more stable, more directly studied metabolite, and most supplement research uses DIM rather than I3C. I3C is the form you get from food; DIM is what your body makes from it.
No human randomized controlled trial has demonstrated that I3C supplementation prevents cancer. It shows interesting signals in laboratory studies and small trials of HPV-related conditions, but extrapolating those findings to cancer prevention in the general population is not supported by evidence.
Raw broccoli contains glucosinolate precursors that yield roughly 100 to 200 mg of I3C per 100 grams. Cooking, especially boiling, significantly reduces this amount. Supplement doses typically deliver 200 to 400 mg in a single capsule, far exceeding what you'd get from a meal.
Discuss I3C supplements with your oncologist before taking them. The compound's effects on estrogen-metabolizing enzymes could theoretically interact with tamoxifen or other hormonal therapies, and the clinical significance of these interactions isn't fully understood.
I3C doesn't directly raise or lower total estrogen levels. It shifts the pattern of estrogen metabolism toward 2-hydroxyestrone relative to 16Ξ±-hydroxyestrone in short-term studies. Whether this shift has meaningful clinical effects on breast health or cancer risk in humans is not established.
Brussels sprouts, broccoli, cabbage, cauliflower, and kale are all excellent sources. To maximize I3C formation, eat them raw or lightly steamed β prolonged boiling destroys the myrosinase enzyme needed to convert glucosinolates into I3C.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
What Are the Symptoms of Low Aloe Vera? Causes and Treatment
Aloe vera is a plant, not a nutrientβno deficiency exists. Learn the critical gel vs. latex safety distinction, FDA actions, and oral use risks for GLP-1 users.
Read moreSymptoms of Low Barley Grass: Why This Isnβt a Real Deficiency
Barley grass is a plant food, not an essential nutrient. There is no barley grass deficiency. Learn what it actually contains, what the weak evidence shows, and the real safety risks.
Read moreSymptoms of Low 5-HTP (5-Hydroxytryptophan): Causes & Treatment
5-HTP is a serotonin precursor, not a nutrient you can be deficient in. Learn what low serotonin activity means, the real risks of 5-HTP supplements, and safer alternatives.
Read moreSymptoms of Low Astaxanthin: Causes and Treatment
Astaxanthin is a powerful antioxidant found in salmon and shrimp, but there's no such thing as a deficiency. Learn what low intake actually means and what the science says.
Read moreSymptoms of Low Apple Cider Vinegar: Causes and Treatment
Apple cider vinegar is a condiment, not a nutrient β no deficiency syndrome exists. Learn what the research actually shows about ACV, blood sugar, and safety risks.
Read moreSymptoms of Low Ashwagandha: Causes and Treatment
Ashwagandha is an adaptogenic herb, not a nutrient. No deficiency syndrome exists. Learn what the evidence shows for stress, thyroid, and safety risks like thyrotoxicosis.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less β care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door β no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.